← Eichor
Study identifier: NCT05034172 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Biomarker Research in Inherited Movement Disorders

Condition: Inherited Movement Disorders · Spinocerebellar Ataxias · Hyperkinetic Disorders  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants4000
Who can joinAll sexes, 7 Years to no upper limit
Healthy volunteersYes

About this study

Inherited movement disorders are rare conditions, whose cumulative prevalence are in the order of 5-10/100,000 inhabitants, in most cases progressive and can lead to a significant loss of autonomy after one or more decades of evolution. They include spinocerebellar ataxias and hyperkinetic disorders (dystonias, choreas, tremor, parkinsonism and myoclonus with variable combination of those, or more complex alteration of movements). The existence of the National Reference Centre (CMR) for Rare Diseases (CMR Neurogenetics, devoted to ataxias and spastic paraparesis, dystonia and rare movement disorders and CMR Huntington, devoted to Huntington Disease) has allowed a more integrated vision of these diseases. This is illustrated, in the same family, by the occurrence of different clinical expressions of spinocerebellar ataxias and hyperkinetic disorders that share the same genetic background. Conversely, different causal mutations within the same gene may have very different ages at onset and a wide range of clinical expression, and the spectrum of new phenotypes linked to a single gene is still expanding . Many ataxia and dystonia genes are involved in similar pathways. There are numerous arguments supporting a share pathogenesis including synaptic transmission and neurodevelopment . BIOMOV project aims to : 1. establish the clinical spectrum and natural history of these diseases, 2. understand the role of genetic and familial factors on the phenotype, 3. elucidate the molecula…

This description comes directly from the study's public registry record.

Talk to the study team

Alexandra DURR, PUPH  ·  142161347  ·  alexandra.durr@aphp.fr

Mariana ATENCIO-SEGURA  ·  142161347  ·  mariana.atencio@icm-institute.org

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital Pitié SalpetrièreParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05034172